Table 3.
Distribution of uptake according to BMB and PET/CT
PET/CT | Global series (N = 268) | R‐CHOP/21 coHORTa (n = 203) | ||||
---|---|---|---|---|---|---|
BMB | ||||||
Negative | Positive | Total | Negative | Positive | Total | |
Negative | 197 | 11 | 208 | 151 | 10 | 161 |
Positive | 36 | 24 | 60 | 26 | 16 | 42 |
Total | 233 | 35 | 268 | 177 | 26 | 203 |
BMB, bone marrow biopsy; PET/CT, possitron emission tomography/computer tomography.
Patients treated with R‐CHOP/21 as first‐line therapeutic strategy.